In Memoriam | Anne Granum

“The HTM community lost another wonderful human being,” the LinkedIn post read.

Canon Medical’s AI-Powered, Premium Large Bore CT Receives FDA Clearance

Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB CT system, giving clinicians the opportunity to see more during radiation therapy planning for accuracy, precision and speed.

FDA Clears MULTIX Impact C Ceiling-Mounted DR System

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new version of the established floor-mounted parent DR system.

FDA Approves Seno Medical’s Breast Cancer Diagnostic Technology

The Center for Devices and Radiological Health (CDRH) of the U.S. Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments Inc.

Analyst: Varian Acquisition Expands Siemens Healthineers Oncology Focus

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion.

Following the announcement that Siemens Healthineers will acquire Varian Medical Systems a lead analyst at GlobalData shared his insights regarding the deal.

“This $16.4 billion deal is the largest transaction by Siemens Healthineers since it was spun-off and formed as a separate business entity by Siemens in 2018. Varian’s oncology related devices and software will allow Siemens Healthineers to expand into the oncology space while also creating a world leader in oncology solutions,” Aurojyoti Bose, lead analyst at GlobalData, said. “Moreover, Varian is considered a leader in radiation therapy and this deal is expected to provide Siemens Healthineers a sizeable market share.”

“The combination will see the creation of a global health care leader offering end-to-end cancer care solutions and is also in line with Siemens Healthineers’ ambitions to become a global leader in oncology solutions by 2025,” he added.

Bose added that the deal is a good sign amid the COVID-19 pandemic.

“Such big-ticket deals amid growing investor cautiousness due to COVID-19 outbreak is a welcome sign and also showcase the resilient nature of the pharmaceutical, health care and medical equipment industries,” he said.



Submit a Comment

Your email address will not be published. Required fields are marked *